altuviiio
(Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl)Bioverativ Therapeutics Inc.
Usage: ALTUVIIIO is indicated for adults and children with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis, on-demand treatment of bleeding episodes, and perioperative management of bleeding. It is not intended for treating von Willebrand disease.